La maladie de Kahler = MyelomaDUPONT, T; GOMEZ, J; CUVILLIER, P et al.Médecine interne (Paris). 1983, Vol 18, Num 4, pp 190-196, issn 0025-6781Article

Characterization of polyclonal autoantibodies specific for β2-microglobulin in multiple myeloma seraVINCENT, C; REVILLARD, J.-P; BATAILLE, R et al.Clinical and experimental immunology (Print). 1983, Vol 54, Num 3, pp 689-696, issn 0009-9104Article

Clinical observations showing the role of some factors in the etiology of multiple myelomaAKSOY, M; ERDEM, S; DINCOL, G et al.Acta haematologica. 1984, Vol 71, Num 2, pp 116-120, issn 0001-5792Article

Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cellsBRITO, Jose L. R; DAVIES, Faith E; GONZALEZ, David et al.Journal of immunological methods. 2008, Vol 333, Num 1-2, pp 147-155, issn 0022-1759, 9 p.Article

Les myélomes à IgD. A propos d'une observation personnelle = IgD myelomas. About one personnal observationLUTRINGER, B; SUSSMANN, J; KUNTZ, J. L et al.Journal de médecine de Strasbourg. 1984, Vol 15, Num 3, pp 149-153, issn 0021-7905Article

Méningite plasmocytaire au cours d'un myélome multiple. Observation anatomo-clinique = Plasma cell meningitis in multiple myeloma. A clinical and pathologic studyBOUDOURESQUES, G; PELLISSIER, J. F; GASTAUT, J. A et al.Annales de médecine interne (Paris). 1983, Vol 134, Num 2, pp 117-122, issn 0003-410XArticle

The treatment of multiple myeloma with docetaxel (an ECOG study)FRIEDENBERG, William R; GRAHAM, David; GREIPP, Philip et al.Leukemia research. 2003, Vol 27, Num 8, pp 751-754, issn 0145-2126, 4 p.Article

Prognostic value of the staging system proposed by Merlini, Waldenstöm and Jayakar for multiple myelomaBETTINI, R; STEIDL, L; RAPAZZINI, P et al.Acta haematologica. 1983, Vol 70, Num 6, pp 379-385, issn 0001-5792Article

Facteurs pronostiques dans le myélome multiple: analyse critique à partir de quatre-vingt-quatre patients = Prognostic factors in multiple myeloma-critical analysis in eighty-four patientsBENITEZ, O; DE GRAMONT, A; HUBERT, D et al.La Semaine des hôpitaux de Paris. 1984, Vol 60, Num 40, pp 2791-2794, issn 0037-1777Article

Multiple myeloma in a pair of monozygotic twins: the first reported caseJUDSON, I. R; WILTSHAW, E; NEWLAND, A. C et al.British journal of haematology. 1985, Vol 60, Num 3, pp 551-554, issn 0007-1048Article

Incompletë pyroglobulin-gamma disease in a patient with osteosclerotic myelomaRUIZ-ARGUELLES, A; VALLS-DE-RUIZ, M; DOMINGUEZ-BARRANCO, A et al.Scandinavian journal of haematology. 1984, Vol 33, Num 4, pp 351-355, issn 0036-553XArticle

A study of certain functional parameters of monocytes from patients with multiple myeloma: comparison with monocytes from healthy individualsBLOM, J; NIELSEN, H; OLESEN LARSEN, S et al.Scandinavian journal of haematology. 1984, Vol 33, Num 5, pp 425-431, issn 0036-553XArticle

Irradiation hémi-corporelle et myélome = Helf body irradiation and myelomeLACROZE, M; DUTOU, L.Journal de médecine de Lyon (Lyon. 1864). 1985, Vol 66, Num 1409, pp 579-581, issn 0021-7883Article

Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma = Différences clinique, morphologique et de cinétique cellulaire dans les myélomes multiples, les gammopathies monoclonales de nature indéterminée et les myélomes multiples paucisymptomatiquesGREIPP, P. R; KYLE, R. A.Blood. 1983, Vol 62, Num 1166-171, issn 0006-4971Article

Proteomic analysis of multiple myeloma: Current status and future perspectivesFENG GE; BI, Li-Jun; TAO, Sheng-Ce et al.Proteomics. Clinical applications (Print). 2011, Vol 5, Num 1-2, pp 30-37, issn 1862-8346, 8 p.Article

Le myélome multiple chez les sujets âgés de plus de quatre-vingts ans: facteurs pronostiques = Multiple myeloma in patients above eighty years of age. Pronostic factorsPASCAUD, F; TAVERNIER, C; LAVAULT, J. F et al.La Semaine des hôpitaux de Paris. 1989, Vol 65, Num 42, pp 2577-2581, issn 0037-1777, 5 p.Article

Treatment of multiple myeloma with recombinant α-interferonQUESADA, J. R; ALEXANIAN, R; HAWKINS, M et al.Blood. 1986, Vol 67, Num 2, pp 275-278, issn 0006-4971Article

Analysis and management of renal failure in fourth MRC myelomatosis trialBritish medical journal (1857). 1984, Vol 288, Num 6428, pp 1411-1416, issn 0007-1447Article

Myélome multiple = Multiple myelomaSOLAL-CELIGNY, P.Revue de médecine et d'internat. 1985, Num 5, pp 11-14Article

Farming and mortality from multiple myeloma: a case-control study with the use of death certificates = Agriculture et mortalité par myélome multiple: une étude cas-témoins avec utilisation des certificats de décèsCANTOR, K. P; BLAIR, A.Journal of the National Cancer Institute. 1984, Vol 72, Num 2, pp 251-255, issn 0027-8874Article

Heterochromatic variants and their association with neoplasias. III: Multiple myelomaRANNI, N. S. M; LABAL DE VINUESA, M; MUDRY DE PARGAMENT, M et al.Cancer genetics and cytogenetics. 1987, Vol 28, Num 1, pp 101-105, issn 0165-4608Article

Detection and identification of serum monoclonal immunoglobulin by immunoisoelectric focusing: limits of sensitivity and use during relapse of multiple myeloma = Dépistage et identification d'une immunoglobuline monoclonale sérique par focalisation immunoisoélectrique. Limites de la sensibilité et utilisation dans les récidives de myélome multipleSINCLAIR, D; KUMARARATNE, D. S; STOTT, D. I et al.Journal of clinical pathology. 1984, Vol 37, Num 3, pp 255-262, issn 0021-9746Article

Prognostic relevance of cellular morphology in multiple myeloma = Signification pronostique de la morphologie cellulaire dans le myélome multipleFRITZ, E; LUDWIG, H; KUNDI, M et al.Blood. 1984, Vol 63, Num 5, pp 1072-1079, issn 0006-4971Article

Contestation d'une critique concernant la comparaison de deux classifications pronostiques du myélome multiple = Contestation of a criticism about the comparison of two pronostic staging systems for multiple myelomaPESCE, A; CASSUTO, J. P; GRISOT, C et al.Nouvelle revue française d'hématologie. 1984, Vol 26, Num 6, issn 0029-4810, 401Article

Prednisone pulse therapy for refractory myeloma = Traitement par doses élevées intermittentes de prednisone dans le myélome réfractaireALEXANIAN, R; BOH SENG YAP; BODEY, G. P et al.Blood. 1983, Vol 62, Num 3, pp 572-577, issn 0006-4971Article